47 related articles for article (PubMed ID: 20361941)
1. Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells.
Wu ZZ; Lu HP; Chao CC
Biochem Pharmacol; 2010 Jul; 80(2):262-76. PubMed ID: 20361941
[TBL] [Abstract][Full Text] [Related]
2. Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes.
Mezencev R; Matyunina LV; Wagner GT; McDonald JF
Cancer Gene Ther; 2016 Dec; 23(12):446-453. PubMed ID: 27910856
[TBL] [Abstract][Full Text] [Related]
3. Knowledge-guided gene prioritization reveals new insights into the mechanisms of chemoresistance.
Emad A; Cairns J; Kalari KR; Wang L; Sinha S
Genome Biol; 2017 Aug; 18(1):153. PubMed ID: 28800781
[TBL] [Abstract][Full Text] [Related]
4. Systematic functional identification of cancer multi-drug resistance genes.
Lau MT; Ghazanfar S; Parkin A; Chou A; Rouaen JR; Littleboy JB; Nessem D; Khuong TM; Nevoltris D; Schofield P; Langley D; Christ D; Yang J; Pajic M; Neely GG
Genome Biol; 2020 Feb; 21(1):27. PubMed ID: 32028983
[TBL] [Abstract][Full Text] [Related]
5. Role of MARK2 in the nervous system and cancer.
Lei Y; Zhang R; Cai F
Cancer Gene Ther; 2024 Apr; 31(4):497-506. PubMed ID: 38302729
[TBL] [Abstract][Full Text] [Related]
6. H1.0 induces paclitaxel-resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor.
Kohli A; Huang SL; Chang TC; Chao CC; Sun NK
Cancer Sci; 2022 Aug; 113(8):2616-2626. PubMed ID: 35639349
[TBL] [Abstract][Full Text] [Related]
7. A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma.
Liu Y; Song Y; Cao M; Fan W; Cui Y; Cui Y; Zhan Y; Gu R; Tian F; Zhang S; Cai L; Xing Y
Clin Transl Med; 2022 Apr; 12(4):e836. PubMed ID: 35485206
[TBL] [Abstract][Full Text] [Related]
8. Identification of new proteins related with cisplatin resistance in Saccharomyces cerevisiae.
Burgos-Molina AM; Mercado-Sáenz S; Cárdenas C; López-Díaz B; Sendra-Portero F; Ruiz-Gómez MJ
Appl Microbiol Biotechnol; 2021 Mar; 105(5):1965-1977. PubMed ID: 33576883
[TBL] [Abstract][Full Text] [Related]
9. Impaired G2/M cell cycle arrest induces apoptosis in pyruvate carboxylase knockdown MDA-MB-231 cells.
Rattanapornsompong K; Khattiya J; Phannasil P; Phaonakrop N; Roytrakul S; Jitrapakdee S; Akekawatchai C
Biochem Biophys Rep; 2021 Mar; 25():100903. PubMed ID: 33490650
[TBL] [Abstract][Full Text] [Related]
10. Molecular Analysis of the Interaction between Human PTPN21 and the Oncoprotein E7 from Human Papillomavirus Genotype 18.
Lee HS; Kim MW; Jin KS; Shin HC; Kim WK; Lee SC; Kim SJ; Lee EW; Ku B
Mol Cells; 2021 Jan; 44(1):26-37. PubMed ID: 33431714
[TBL] [Abstract][Full Text] [Related]
11. MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells.
Wei X; Xu L; Jeddo SF; Li K; Li X; Li J
Am J Transl Res; 2020; 12(5):1807-1823. PubMed ID: 32509178
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair.
Xu L; Sun Z; Wei X; Tan H; Kong P; Li Z; Yang Q; Dai E; Li J
J Bone Oncol; 2020 Aug; 23():100290. PubMed ID: 32368441
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma.
Ruckert MT; de Andrade PV; Santos VS; Silveira VS
Cell Mol Life Sci; 2019 Jul; 76(13):2571-2592. PubMed ID: 30982078
[TBL] [Abstract][Full Text] [Related]
14. Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.
Annadurai N; Agrawal K; Džubák P; Hajdúch M; Das V
Cell Mol Life Sci; 2017 Nov; 74(22):4159-4169. PubMed ID: 28634681
[TBL] [Abstract][Full Text] [Related]
15. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
Minemura H; Takagi K; Sato A; Takahashi H; Miki Y; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T
Cancer Sci; 2016 Dec; 107(12):1898-1908. PubMed ID: 27627783
[TBL] [Abstract][Full Text] [Related]
16. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of cisplatin resistance in cervical cancer.
Zhu H; Luo H; Zhang W; Shen Z; Hu X; Zhu X
Drug Des Devel Ther; 2016; 10():1885-95. PubMed ID: 27354763
[TBL] [Abstract][Full Text] [Related]
18. Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.
Siraj AK; Masoodi T; Bu R; Beg S; Al-Sobhi SS; Al-Dayel F; Al-Dawish M; Alkuraya FS; Al-Kuraya KS
Am J Hum Genet; 2016 Jun; 98(6):1170-1180. PubMed ID: 27236916
[TBL] [Abstract][Full Text] [Related]
19. Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells.
Lin YT; Chao CC
Oncotarget; 2015 Nov; 6(36):38999-9017. PubMed ID: 26517516
[TBL] [Abstract][Full Text] [Related]
20. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
Liu YC; Chang PY; Chao CC
Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
